Testing effectiveness (Phase 2)UnknownNCT04290325What this trial is testingHMPL-453 in Advanced Malignant MesotheliomaWho this might be right forAdvanced Malignant Mesothelioma Hutchison Medipharma Limited 27
Early research (Phase 1)Study completedNCT00066651What this trial is testingImmunotoxin Therapy in Treating Patients With Advanced Solid TumorsWho this might be right forCervical CancerFallopian Tube CancerHead and Neck Cancer+5 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT03213301What this trial is testingLurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma.Who this might be right forMalignant Pleural Mesothelioma, Advanced Swiss Cancer Institute 42
Early research (Phase 1)Active Not RecruitingNCT04328844What this trial is testingAssess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic CancersWho this might be right forSolid Tumor, AdultNon-Hodgkin Lymphoma, AdultNSCLC+2 more iOnctura 210
Testing effectiveness (Phase 2)Active Not RecruitingNCT00715611What this trial is testingPleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural MesotheliomaWho this might be right forMesothelioma Memorial Sloan Kettering Cancer Center 65
Testing effectiveness (Phase 2)Looking for participantsNCT06051695What this trial is testingEvaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionWho this might be right forSolid Tumor, AdultColorectal CancerNSCLC+17 more A2 Biotherapeutics Inc. 474
Not applicableStudy completedNCT01401907What this trial is testingEarly Palliative Care in Advanced Lung and Gastrointestinal MalignanciesWho this might be right forNon-small Cell Lung CancerSmall Cell Lung CancerMesothelioma+4 more Massachusetts General Hospital 351
Testing effectiveness (Phase 2)Active Not RecruitingNCT06638931What this trial is testingAgnostic Therapy in Rare Solid TumorsWho this might be right forUrachal CancerParathyroid CarcinomaFibrolamellar Carcinoma+38 more Instituto do Cancer do Estado de São Paulo 28
Testing effectiveness (Phase 2)UnknownNCT05199584What this trial is testingA Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function MutationsWho this might be right forSolid Tumors With PTCH1 Loss-of-function Mutations Endeavor Biomedicines, Inc. 44
Large-scale testing (Phase 3)Looking for participantsNCT06097728What this trial is testingMEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural MesotheliomaWho this might be right forUnresectable Pleural Mesothelioma AstraZeneca 825
Early research (Phase 1)Study completedNCT04672434What this trial is testingSym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesWho this might be right forMetastatic CancerSolid Tumor Symphogen A/S 48
Testing effectiveness (Phase 2)Study completedNCT01486368What this trial is testingA Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural MesotheliomaWho this might be right forMalignant Pleural Mesothelioma NCIC Clinical Trials Group 17
Early research (Phase 1)Study completedNCT03517488What this trial is testingXmAb®20717 in Subjects With Selected Advanced Solid TumorsWho this might be right forMelanomaBreast CarcinomaHepatocellular Carcinoma+25 more Xencor, Inc. 150
Early research (Phase 1)Active Not RecruitingNCT03983954What this trial is testingNaptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.Who this might be right forER+ Breast CancerOvarian CancerCervical Squamous Cell Carcinoma+17 more NeoTX Therapeutics Ltd. 120
Early research (Phase 1)Active Not RecruitingNCT05544929What this trial is testingSafety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced CancersWho this might be right forCarcinoma, Non-Small-Cell LungCutaneous MelanomaCarcinoma, Renal Cell+9 more Novartis Pharmaceuticals 126
Early research (Phase 1)Not Yet RecruitingNCT06652529What this trial is testingPhase 1 Dose Escalation and Expansion to Evaluate AROG4-01 in Patients With Advanced Solid TumorsWho this might be right forSolid Tumors (Phase 1)MesotheliomaColorectal Carcinoma+2 more Aromics Therapeutics 35
Not applicableStudy completedNCT05324436What this trial is testingYervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM)Who this might be right forMesothelioma, Malignant Bristol-Myers Squibb 75
Early research (Phase 1)Looking for participantsNCT06452160What this trial is testingBGC515 Capsules in Subjects With Advanced Solid TumorsWho this might be right forMesotheliomaEpithelioid Hemangioendothelioma(EHE)Solid Tumor BridGene Biosciences Inc. 103
Early research (Phase 1)UnknownNCT05498597What this trial is testingAMT-151 in Patients With Selected Advanced Solid TumoursWho this might be right forAdvanced Solid TumorAdvanced CancerAdvanced Carcinoma+16 more Multitude Therapeutics Inc. 30
Testing effectiveness (Phase 2)Ended earlyNCT03233724What this trial is testingOral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal CarcinomasWho this might be right forCarcinoma, Non-Small-Cell LungLung CancerNon-Small Cell Lung Cancer+2 more National Cancer Institute (NCI) 9